12 new epilepsy drugs usher in ‘era of abundance’
MAYWOOD, Ill. — A dozen new epilepsy drugs are giving doctors and patients more options, but making treatment decisions more complex, a Loyola epilepsy specialist reports in the journal Neurologic Clinics.
“Clinicians practice in an era of abundan…
Genetic defect found to cause severe epilepsy and mental retardation
BEER-SHEVA, Israel, October 12, 2010 — A research team at Ben-Gurion University of the Negev and Soroka University Medical Center in Beer-Sheva, Israel has detected a genetic mutation resulting in a progressive disease of severe mental retardatio…
Scientists find link in humans between nerve cell production, memory
Production of new nerve cells in the human brain is linked to learning and memory, according to a new study from the University of Florida. The research is the first to show such a link in humans. The findings, published online and in an upcoming pr…
Newer Epilepsy Drug Has Worse Side Effects Than Older Drug
Two commonly prescribed epilepsy drugs have varied cognitive side effects on patients, report doctors from Georgetown University Medical Center. Their findings are published in the May 13 issue of the journal Neurology. In a double-blind, randomized study, researchers looked at 2 drugs, valproate–released in 1978 for the treatment of epileptic seizures, and topiramate, approved by the FDA in late 1996. Each drug was added to carbamazepine, a standard epilepsy treatment, and then given to patients with epilepsy. The cognitive effects on those patients taking topiramate were slightly, although noticeably, worse than those taking the older valproate for a subset of patients.